Functionalization of the plastic chips for selective immobilization of biomolecules is one of the key challenges to be addressed in commercialization of the next-generation point-of-care (POC) diagnostics devices. Multistep liquid-phase deposition process requires a large quantity of solvent to be used in anhydrous conditions, providing quantity of industrial liquid waste. We, in this work, have demonstrated a solventless plasma-based process that integrates low-cost, high throughput, high reproducibility and ecofriendly process for the functionalization of POC device platforms. Amine functionalities have been deposited by plasma-enhanced chemical vapour deposition 2 (PECVD) using a new precursor. For a successful and efficient plasma functionalization process, an understanding of the influence of plasma process parameters on the surface characteristics is essential. The influence of the plasma RF power and the deposition time on the deposited amount of amino functionalities and on their capacity to immobilize nano-objects (i.e., nanoparticles) and biomolecules (i.e. DNA) was examined. Surfacial properties were related to the binding capacity of the films and to the amino content, as revealed by the Ònanoparticle approachÓ and DNA attachment experiments. The key process determinants were to have a sufficient power in the plasma to activate and partially fragment the monomer but not too much as to lose the reactive amine functionality, and sufficient deposition time to develop a reactive layer but not to consume or erode the amine reactivity. An immunoassay performed using human immunoglobulin (IgG) as a model analyte shows an improvement of the detection limit by two orders of magnitude beyond that obtained using devices activated by liquid-phase reaction.